PORTABLE, RELIABLE AND RAPID, WITH RESULTS ON THE SPOT, ALL IN THE SIZE OF A TOASTER. DIFFERENCE-MAKING INNOVATION.
In the fight against COVID-19, having multiple tests for different settings and stages of a person's infection is key, from high-volume laboratory capabilities to fast solutions that give results on the spot, from tests that detect the active virus to tests that detect antibodies in people who were previously infected. The portable, rapid molecular ID NOW COVID-19 test has emerged as a critical part of this arsenal, allowing fast diagnosis — with results in 13 minutes or less — in a variety of locations such as physicians' offices, urgent care clinics and other point-of-care locations. We have shipped nearly 4.5 million of our rapid ID NOW tests to all 50 states, Washington D.C., Puerto Rico and the Pacific Islands. Find out more about this innovative technology and its impact here.
How advanced molecular testing technology detects novel coronavirus.
How ID NOW is bringing rapid COVID-19 testing to frontlines of patient care.
Point-of-care tests are critical to help fight the novel coronavirus pandemic.
Reliable test results depend on many factors, conformity to test design.
ID NOW delivers results in minutes where they're needed most during COVID-19.
Abbott's approach to research and development of COVID-19 diagnostic tests.
An Abbott infectious disease expert’s steps to effectively test for coronavirus.
With novel coronavirus, use direct swab method for best results on ID NOW.
Study’s early results reflect customer view, Abbott’s Dr. Philip Ginsburg says.
GoHealth Urgent Care: Rapid test kept COVID-19 patient from boarding plane.
Northwestern Medicine doctor tells WGN that ID NOW works best near patients.
At Physician's Immediate Care, same high confidence in accuracy of results.
At Physicians Immediate Care, ID NOW helps them slow the spread of COVID-19.
Properly used, ID NOW “very effective,” Abbott’s John R. Hackett Jr. tells CNN.
For American Family Care, ID NOW is vital tool to helping its community.
(May 22, 2020) Bruce Japsen / Forbes
(May 18, 2020) Stuart Varney / Fox Business
(April 30, 2020) Lonnie Wong / FOX40
(March 31, 2020) Dan Krauth / WABC-TV New York City
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.